Compare TECK & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECK | VEEV |
|---|---|---|
| Founded | 1913 | 2007 |
| Country | Canada | United States |
| Employees | 7200 | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 28.2B |
| IPO Year | N/A | 2013 |
| Metric | TECK | VEEV |
|---|---|---|
| Price | $51.61 | $174.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 26 |
| Target Price | $53.17 | ★ $283.80 |
| AVG Volume (30 Days) | ★ 4.6M | 1.8M |
| Earning Date | 04-23-2026 | 03-04-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 5.44 |
| Revenue | N/A | ★ $1,104,081,000.00 |
| Revenue This Year | $12.43 | $14.26 |
| Revenue Next Year | $4.02 | $11.80 |
| P/E Ratio | $32.94 | ★ $32.30 |
| Revenue Growth | N/A | ★ 28.05 |
| 52 Week Low | $28.32 | $168.14 |
| 52 Week High | $62.41 | $310.50 |
| Indicator | TECK | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 39.11 |
| Support Level | $41.39 | $169.92 |
| Resistance Level | $52.24 | $184.71 |
| Average True Range (ATR) | 1.78 | 6.24 |
| MACD | 0.22 | -0.57 |
| Stochastic Oscillator | 90.01 | 19.57 |
Teck is a base metals miner with copper and zinc operations in Canada, the United States, Chile, and Peru. After selling its metallurgical coal business, copper is now its major commodity by EBITDA contribution, followed by zinc. Teck is a top-three zinc miner. Its major new copper mine in Chile at the majority-owned Quebrada Blanca 2, in partnership with Sumitomo, will drive an increase in Teck's attributable copper production by roughly 75%. Along with a number of additional copper growth options, Teck's strategy is to rebalance its portfolio to low-carbon metals such as copper. It sold its oil sands business in early 2023 and its coal business in mid-2024. In September 2025, it agreed to merge with Anglo American.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.